Phase 1 clinical trials are proceeding now in US adults (first-in-human) followed by dose-escalation among African adults with future age-de-escalation to children with SchistoShield (Sm-p80 expressed in E

Date: March 15, 2009 Event: Annual Conference for the Society for Personality Assessment Location: Chicago, IL Lauren Renee Emery Borderline personality features and bulimic symptoms: The mediating role of neuroticism Date: March 8, 2009 Event: 2009 Society of Personality Assessment, Location: Chicago, IL Alyssa Monika Minnick Borderline Personality features and bulimic symptoms: The Mediating role of neuroticism Date: March 8, 2009 Event: Society of Personality Assessment (SPA)\ Location: Chicago, IL Alyssa Monika Minnick Borderline Personality Features and Bulimic Symptoms: The Mediating Role of Neuroticism Date: March 6, 2009 Event: Eastern Psychological Association Conference Location: Pittsburgh, PA Christina Lauren Burg Relationship Between Recall of Illness Episodes and Symptom Reports Date: March 6, 2009 Event: Eastern Psychological Association Conference Location: Pittsburgh, PA Elizabeth Catherine Conti Relationship Between Recall of Illness Episodes and Symptom Reports Date: March 6, 2009 Event: Eastern Psychological Association 2009 Conference Location: Pittsburgh, PA Laura Ann Smith Public Concepts of Eating Disorder Diagnosis: How Far is Too Far

Mass spectrometry (LC-MS) identity confirmation
Multiple studies and clinical trials have demonstrated that Zooki Liposomal Encapsulation provides nutrients with up to 4x higher absorption into the bloodstream compared to conventional supplements
The Ipamorelin and CJC-1295 combination often improves sleep as a side benefit